DiaSorin S.p.A. (DSRLF)
USD 109.01
(0.0%)
USD 109.01
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.12 Billion USD | -10.09% |
| 2022 | 1.25 Billion USD | -10.23% |
| 2021 | 1.39 Billion USD | 4484.74% |
| 2020 | 30.45 Million USD | 24.46% |
| 2019 | 24.46 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 808.24 Million EUR | -26.63% |
| 2024 Q2 | 903.38 Million EUR | 20.61% |
| 2023 Q4 | 1.08 Billion EUR | -4.71% |
| 2023 FY | 1.12 Billion USD | -10.09% |
| 2023 Q2 | 1.16 Billion USD | -11.95% |
| 2023 Q3 | 1.13 Billion EUR | -2.57% |
| 2023 Q1 | 1.32 Billion EUR | 5.71% |
| 2022 Q3 | 1.38 Billion EUR | 6.15% |
| 2022 FY | 1.25 Billion USD | -10.23% |
| 2022 Q1 | 1.52 Billion EUR | 24.45% |
| 2022 Q2 | 1.3 Billion EUR | -14.61% |
| 2022 Q4 | 1.25 Billion USD | -9.55% |
| 2021 Q2 | 491.84 Million EUR | 1052.6% |
| 2021 FY | 1.39 Billion USD | 4484.74% |
| 2021 Q3 | 1.59 Billion EUR | 223.81% |
| 2021 Q4 | 1.22 Billion EUR | -22.88% |
| 2021 Q1 | 42.67 Million EUR | 14.72% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q3 | 32.24 Million EUR | 25.14% |
| 2020 Q4 | 37.19 Million EUR | 15.36% |
| 2020 FY | 30.45 Million USD | 24.46% |
| 2020 Q2 | 25.76 Million EUR | 0.0% |
| 2019 FY | 24.46 Million USD | 0.0% |
| 2019 Q4 | 27.44 Million EUR | 199.72% |
| 2019 Q3 | 9.15 Million EUR | -67.61% |
| 2019 Q2 | 28.27 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2018 Q4 | 92.79 Thousand EUR | -99.36% |
| 2018 Q3 | 14.39 Million EUR | 13015.01% |
| 2018 Q2 | 109.76 Thousand EUR | -97.59% |
| 2018 Q1 | 4.55 Million EUR | 3624.43% |
| 2017 Q4 | 122.37 Thousand EUR | -97.53% |
| 2017 Q2 | 13.86 Million EUR | -77.86% |
| 2017 Q1 | 62.62 Million EUR | 118.01% |
| 2017 Q3 | 4.96 Million EUR | -64.2% |
| 2016 Q2 | 56.17 Million EUR | 0.0% |
| 2016 Q1 | - EUR | 0.0% |
| 2016 Q3 | 40.16 Million EUR | -28.49% |
| 2016 Q4 | 28.72 Million EUR | -28.49% |
| 2015 Q1 | 112.8 Thousand EUR | -55.62% |
| 2015 Q4 | - EUR | 0.0% |
| 2015 Q3 | - EUR | -100.0% |
| 2015 Q2 | 118.07 Thousand EUR | 4.67% |
| 2014 Q1 | 446.43 Thousand EUR | -23.36% |
| 2014 Q2 | 431.24 Thousand EUR | -3.4% |
| 2014 Q3 | 263.77 Thousand EUR | -38.83% |
| 2014 Q4 | 254.19 Thousand EUR | -3.63% |
| 2013 Q2 | 687.68 Thousand EUR | -88.48% |
| 2013 Q3 | 583.33 Thousand EUR | -15.17% |
| 2013 Q1 | 5.96 Million EUR | 0.0% |
| 2013 Q4 | 582.52 Thousand EUR | -0.14% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -18780312.033% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -86744.899% |
| Biocept, Inc. | 10.37 Million USD | -10760.961% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | -2096.197% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | -1740.455% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -206155.761% |
| iMD Companies, Inc. | 1.1 Million USD | -101998.345% |
| IDenta Corp. | 428.17 Thousand USD | -263068.585% |
| Interpace Biosciences, Inc. | 4.24 Million USD | -26457.264% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -405232.634% |
| NovelStem International Corp. | 3.32 Million USD | -33793.553% |
| Optigenex Inc. | 4.42 Million USD | -25353.076% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -68987.966% |
| Response Genetics, Inc | 4.91 Million USD | -22812.255% |
| Rennova Health, Inc. | 359.19 Thousand USD | -313610.101% |
| RushNet, Inc. | 4.25 Million USD | -26398.628% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -452349.196% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -141028.114% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -195399.638% |
| Todos Medical Ltd. | 33 Million USD | -3314.517% |